Maria Luz Amador | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Maria Luz Amador is active.

Explore More

Publication

Featured researches published by Maria Luz Amador.

International Journal of Radiation Oncology Biology Physics | 2007

Phase I/II Study of Concurrent Erlotinib and Chemoradiation for Post-Resected Locally Advanced Squamous Head and Neck Cancer (HNSCC): A Gicor Study

F. Arias de la Vega; Ismael Herruzo; M. de las Heras; A. de la Torre; L. del Río; Jorge E. Contreras; I. Prieto; J.A. García Saenz; Maria Luz Amador; Felipe A. Calvo

Journal of Thoracic Oncology | 2007

P3-130: A large Spanish experience with erlotinib in advanced non–small cell lung cancer

Luis Paz-Ares; J. Gonzalez-Larriba; Nuria Viñolas; Alberto Arízcum; David Gutiérrez-Abad; Caterina Madroñal; José Ramón Delgado; Purificación Martínez Del Prado; Maria Luz Amador; Bartomeu Massuti

International Journal of Radiation Oncology Biology Physics | 2007

Randomized Phase II Trial of Radiotherapy With or Without Erlotinib in Patients With Locally Advanced or Unresectable Non-Small Cell Lung Cancer

E. Martinez; M.T. Martínez; A. de la Torre; F. Valcárcel; Aurelio Álvarez Pérez; Manuel Domine; Maria Luz Amador

Journal of Clinical Oncology | 2016

Phase I/II study of concurrent erlotinib and chemoradiation for post-resected locally advanced squamous head and neck cancer (HNSCC): A GICOR study

F. Arias de la Vega; Ismael Herruzo; M. de las Heras; A. de la Torre; L. del Rio; Jorge E. Contreras; I. Prieto; Javier E. García de Alba García; Maria Luz Amador; Felipe A. Calvo

Archive | 2009

Revisin de anlisis econmicos sobre tecnologas emergentes en oncologa

Luis Quecedo Gutierrez; Juan del Llano Senaris; Maria Luz Amador

Journal of Thoracic Oncology | 2007

P3-083: Erlotinib as a single agent in the treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC) and good performance status

Pilar Garrido; Manuel Cobo; Montserrat Domenech; Romà Bastús; Antonio Galan; Inmaculada Maestu; Miguel Angel Muñoz; Jesús García-Donas; Maria Luz Amador; Bartomeu Massuti

Journal of Thoracic Oncology | 2007

Erlotinib as single agent in elderly patients (p) with advanced or metastatic NSCLC: P3-061

Vicente Alberola; O. Gallego; Guillermo Lopez Vivanco; Carlos Mesia; Juana Oramas; José Manuel Trigo; Juan Antonio Virizuela; Carlos Camps; Maria Luz Amador; Bartomeu Massuti

Journal of Thoracic Oncology | 2007

P3-113: Randomized phase II trial of radiotherapy with or without Erlotinib in patients with locally advanced or unresectable non small cell lung cancer

Enrique Martinez; Maria Teresa Martinez; Alejandro de la Torre; F. Valcárcel; Ana Perez Casas; Manuel Domine; Maria Luz Amador

Journal of Thoracic Oncology | 2007

P3-095: Erlotinib in advanced squamous cell carcinoma of the lung

Dolores Isla; Ulpiano Jimenez; Juan Jose Valverde; Javier Garcia; Jose Alfredo Almenarez; Jose Andres Moreno; Pedro Valero; Reyes Bernabe; Maria Luz Amador; Ares Luis Paz

Journal of Thoracic Oncology | 2007

P3-061: Erlotinib as single agent in elderly patients (p) with advanced or metastatic NSCLC

Vicente Alberola; O. Gallego; Guillermo López Vivanco; Carlos Mesia; Juana Oramas; José Manuel Trigo; Juan Antonio Virizuela; Carlos Camps; Maria Luz Amador; Bartomeu Massuti

Explore More